Waverton Investment Management Ltd Has $547,000 Stake in Danaher Corporation $DHR

Waverton Investment Management Ltd increased its position in shares of Danaher Corporation (NYSE:DHR) by 12.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,770 shares of the conglomerate’s stock after buying an additional 316 shares during the period. Waverton Investment Management Ltd’s holdings in Danaher were worth $547,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. MGO One Seven LLC raised its stake in Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after acquiring an additional 20,813 shares in the last quarter. Chicago Capital LLC raised its stake in Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after acquiring an additional 1,391 shares in the last quarter. UniSuper Management Pty Ltd raised its stake in Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after acquiring an additional 2,667 shares in the last quarter. Asahi Life Asset Management CO. LTD. acquired a new position in Danaher during the first quarter worth about $539,000. Finally, ASR Vermogensbeheer N.V. raised its stake in Danaher by 1.9% during the second quarter. ASR Vermogensbeheer N.V. now owns 322,924 shares of the conglomerate’s stock worth $63,787,000 after acquiring an additional 6,136 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on DHR. UBS Group lowered their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research note on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft upped their price objective on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Evercore ISI upped their price objective on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Finally, Robert W. Baird set a $247.00 target price on shares of Danaher in a research report on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Price Performance

Danaher stock opened at $212.34 on Thursday. The stock has a market capitalization of $149.99 billion, a price-to-earnings ratio of 43.78, a PEG ratio of 3.28 and a beta of 0.81. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The stock’s 50 day moving average price is $203.83 and its two-hundred day moving average price is $200.07.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were given a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.